Coya Therapeutics, Inc. (COYA) delivered a return of -8.12% over the past year. Since COYA does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Coya Therapeutics, Inc. one year ago would be worth $9,188 today, representing a loss of $812.

Coya Therapeutics, Inc. (COYA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For COYA, the total return equals the price-only return.

No, Coya Therapeutics, Inc. (COYA) underperformed the S&P 500 by 28.96 percentage points over the past year. COYA delivered a total return of -8.12%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed COYA by 28.96pp during this period.

Coya Therapeutics, Inc. (COYA) experienced a maximum drawdown of -48.64% over the past year, declining from its peak on 2025-10-22 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Coya Therapeutics, Inc. (COYA)'s long-term returns with dividends reinvested. Over 10 years, the total return is 16.4% (1.5% CAGR) — $10,000 would have grown to $11,641. Over 20 years: 16.4% total return (0.8% CAGR) — $10,000 → $11,641. Over 30 years: 16.4% total return (0.5% CAGR) — $10,000 → $11,641. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Coya Therapeutics, Inc.'s best calendar year was 2023 with a total return of 59.4%. Its worst year was 2024 with a total return of -17.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 77.0 percentage points.